Literature DB >> 22497776

Small fiber neuropathy in Fabry disease.

Marieke Biegstraaten1, Carla E M Hollak, Mayienne Bakkers, Catharina G Faber, Johannes M F G Aerts, Ivo N van Schaik.   

Abstract

Previous studies have explicitly shown that small nerve fibers are affected in Fabry disease which is assumed to cause the severe neuropathic pain that patients may have from childhood on. Neuropathic pain and small fiber neuropathy characteristics have therefore been considered as appropriate study endpoints in studies on the efficacy of enzyme replacement therapy. However, the relationship between small fiber neuropathy characteristics and pain, as well as the course of small fiber neuropathy in Fabry disease is still uncertain. In this article a comprehensive overview of the existing literature on small nerve fiber function and structure and the relationship with pain, age and disease severity is presented supplemented with data from the Dutch Fabry cohort, with the aim to identify consensus as well as controversies and to propose a hypothesis on the evolution of neuropathy in Fabry disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22497776     DOI: 10.1016/j.ymgme.2012.03.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  27 in total

1.  Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy.

Authors:  Eefje B Suntjens; Bouwien E Smid; Marieke Biegstraaten; Wouter A Dreschler; Carla E M Hollak; Gabor E Linthorst
Journal:  J Inherit Metab Dis       Date:  2014-11-14       Impact factor: 4.982

Review 2.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

3.  Generalized anhidrosis with preganglionic sudomotor dysfunction in Fabry disease: a case report.

Authors:  Eun Bin Cho; Seung Joo Kim; Tae-Won Yang; Heejeong Jeong; Changhyo Yoon; Seunguk Jung; Ki-Jong Park
Journal:  Clin Auton Res       Date:  2021-04-10       Impact factor: 4.435

4.  Small fibre neuropathy in Fabry disease.

Authors:  A K Bertelsen; C Tøndel; J Krohn; N Bull; J Aarseth; G Houge; S I Mellgren; C A Vedeler
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

5.  Electroneuromyographic Features in Fabry Disease: A Retrospective Review.

Authors:  Çetin Kürşad Akpinar; Hande Türker; Oytun Bayrak; Nilgün Cengiz
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

Review 6.  Fabry disease: what the cardiologist should consider in non-cardiac screening, diagnosis, and management-narrative review.

Authors:  Claudia Regenbogen; Matthias Christoph Braunisch; Christoph Schmaderer; Uwe Heemann
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

7.  Neuropathic pain in a Fabry disease rat model.

Authors:  James J Miller; Kazuhiro Aoki; Francie Moehring; Carly A Murphy; Crystal L O'Hara; Michael Tiemeyer; Cheryl L Stucky; Nancy M Dahms
Journal:  JCI Insight       Date:  2018-03-22

8.  Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease.

Authors:  Ozlem Goker-Alpan; Michael J Gambello; Gustavo H B Maegawa; Khan J Nedd; Daniel J Gruskin; Larry Blankstein; Neal J Weinreb
Journal:  JIMD Rep       Date:  2015-08-25

9.  In Patients with an α-Galactosidase A Variant, Small Nerve Fibre Assessment Cannot Confirm a Diagnosis of Fabry Disease.

Authors:  Linda van der Tol; Camiel Verhamme; Ivo N van Schaik; Anneke J van der Kooi; Carla E M Hollak; Marieke Biegstraaten
Journal:  JIMD Rep       Date:  2015-11-14

Review 10.  Lysosomal storage diseases--the horizon expands.

Authors:  Rose-Mary Naaman Boustany
Journal:  Nat Rev Neurol       Date:  2013-08-13       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.